Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic causes of primary immunodeficiency in the Jordanian population. | Biomed Rep | 2024 | 39268404 | PubTator, text mining | PubMed |
| Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses. | Dermatol Ther (Heidelb) | 2024 | 39264399 | PubTator, text mining | PubMed |
| Role and functional mechanisms of IL‑17/IL‑17R signaling in pancreatic cancer (Review). | Oncol Rep | 2024 | 39219271 | PubTator, text mining | PubMed |
| Recurrent subcutaneous abscesses and pneumonia in a toddler with a novel pathogenic variation in IL-17RA gene. | BMJ Case Rep | 2024 | 39179263 | PubTator, text mining | PubMed |
| Genome-wide large-scale multi-trait analysis characterizes global patterns of pleiotropy and unique trait-specific variants. | Nat Commun | 2024 | 39143063 | PubTator, text mining | PubMed |
| Involvement of IL17A and IL17RA variants in interleukin-17A levels and disease activity in ulcerative colitis. | Cytokine | 2024 | 39111114 | PubTator, text mining | PubMed |
| IL-17A Cytokine-Regulated Glut1 Expression in Placenta Cells. | Curr Issues Mol Biol | 2024 | 39057079 | PubTator, text mining | PubMed |
| MLN4924 alleviates autoimmune myocarditis by promoting Act1 degradation and blocking Act1-mediated mRNA stability. | Int Immunopharmacol | 2024 | 39038386 | PubTator, text mining | PubMed |
| IL-17A produced by POMC neurons regulates diet-induced obesity. | iScience | 2024 | 39027371 | PubTator, text mining | PubMed |
| IL-6 induces Treg dysfunction in desiccating stress-induced dry eye disease. | Exp Eye Res | 2024 | 39009059 | PubTator, text mining | PubMed |
| [IL-17A and IL-17F: from discovery to target of biologics - an illustrative example of translational research]. | Biol Aujourdhui | 2024 | 39007775 | PubTator, text mining | PubMed |
| Cartilage decellularized matrix hydrogel loaded with protocatechualdehyde for targeted epiphycan treatment of osteoarthritis. | Mater Today Bio | 2024 | 38994469 | PubTator, text mining | PubMed |
| Unveiling the Culprit: IL17 Signaling in the Pancreatic Epithelium Drives Tumorigenesis. | Cancer Immunol Res | 2024 | 38990149 | PubTator, text mining | PubMed |
| Eosinophils in hidradenitis suppurativa patients exhibit pro-inflammatory traits, implicating a potential pathogenic role in the disease. | Exp Dermatol | 2024 | 38984465 | PubTator, text mining | PubMed |
| Gut Microbiota Disorder Contributes to the Production of IL-17A That Exerts Chemotaxis via Binding to IL-17RA in Endometriosis. | J Inflamm Res | 2024 | 38974001 | PubTator, text mining | PubMed |
| Sex-dependent APOE4 neutrophil-microglia interactions drive cognitive impairment in Alzheimer's disease. | Nat Med | 2024 | 38961225 | PubTator, text mining | PubMed |
| Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. | Am J Clin Dermatol | 2024 | 38954226 | PubTator, text mining | PubMed |
| Combinatorial actions of IL-22 and IL-17 drive optimal immunity to oral candidiasis through SPRRs. | PLoS Pathog | 2024 | 38949991 | PubTator, text mining | PubMed |
| Impact of Interleukin-17 Receptor A Gene Variants on Asthma Susceptibility and Clinical Manifestations in Children and Adolescents. | Children (Basel) | 2024 | 38929236 | PubTator, text mining | PubMed |
| [Translated article] Comparing the Use of Topical Therapy Along with Anti-IL-17 and Anti-IL-23 to Treat Moderate-to-Severe Psoriasis in the Routine Clinical Practice. | Actas Dermosifiliogr | 2024 | 38815679 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=12